Soleus Capital Management, L.P.
Top Portfolio Positions
93 positions ·
$2,469,218,398 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| KRYS |
Krystal Biotech, Inc.
Healthcare
|
1,153,087 | $297,865,433 | 12.06% | |
| CELC |
Celcuity Inc.
Healthcare
|
1,284,378 | $146,598,904 | 5.94% | |
| TGTX |
Tg Therapeutics, Inc.
Healthcare
|
4,029,319 | $133,853,977 | 5.42% | |
| PODD |
Insulet Corp
Healthcare
|
562,500 | $118,035,000 | 4.78% | |
| NVCR |
NovoCure Ltd
Healthcare
|
10,492,391 | $114,367,061 | 4.63% | |
| UTHR |
UNITED THERAPEUTICS Corp
Healthcare
|
187,187 | $110,998,147 | 4.50% | |
| PRAX |
Praxis Precision Medicines, Inc.
Healthcare
|
330,517 | $106,489,272 | 4.31% | |
| VCEL |
Vericel Corp
Healthcare
|
2,549,079 | $82,003,871 | 3.32% | |
| ALKS |
Alkermes plc.
Healthcare
|
1,970,864 | $69,689,751 | 2.82% | |
| ANIP |
Ani Pharmaceuticals Inc
Healthcare
|
820,243 | $63,076,686 | 2.55% |
Portfolio Trend
25 quarters · across all stocks
Holdings in CCCC
Shares Held
Position Value (USD)
22 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $10,004,367 | 3,803,942 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $7,265,529 | 3,803,942 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $15,659,751 | 7,053,942 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $9,979,887 | 6,978,942 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $11,166,307 | 6,978,942 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $25,124,191 | 6,978,942 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $37,642,777 | 6,603,996 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $18,720,221 | 4,051,996 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $20,089,997 | 2,458,996 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $10,373,377 | 1,835,996 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $5,007,157 | 2,692,020 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $7,403,055 | 2,692,020 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $7,495,242 | 2,387,020 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $14,400,973 | 2,440,843 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $12,642,069 | 1,441,513 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,131,105 | 282,640 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $4,045,015 | 166,736 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $18,068,128 | 561,122 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $33,538,282 | 750,633 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $32,949,482 | 870,758 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $17,165,875 | 464,068 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $8,896,995 | 268,548 | Shares | Sole | 2021-04-29 | |
| No 13F history on record for this holder in this stock. | ||||||